Skip to main navigation Skip to search Skip to main content

An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancer

  • Thomas Powles
  • , Danielle Carroll
  • , Simon Chowdhury
  • , Gwenaelle Gravis
  • , Florence Joly
  • , Joan Carles
  • , Aude Fléchon
  • , Pablo Maroto
  • , Daniel Petrylak
  • , Frédéric Rolland
  • , Natalie Cook
  • , Arjun V. Balar
  • , Srikala S. Sridhar
  • , Matthew D. Galsky
  • , Petros Grivas
  • , Alain Ravaud
  • , Robert Jones
  • , Jan Cosaert
  • , Darren Hodgson
  • , Iwanka Kozarewa
    • Richard Mather, Robert McEwen, Florence Mercier, Dónal Landers

Research output: Contribution to journal › Article › peer-review

94 Scopus citations

Fingerprint

Dive into the research topics of 'An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancer'. Together they form a unique fingerprint.
Sort by

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases